| First Author | Shen C | Year | 2017 |
| Journal | EBioMedicine | Volume | 16 |
| Pages | 238-250 | PubMed ID | 28161398 |
| Mgi Jnum | J:276195 | Mgi Id | MGI:6296525 |
| Doi | 10.1016/j.ebiom.2017.01.040 | Citation | Shen C, et al. (2017) Angiotensin-II-induced Muscle Wasting is Mediated by 25-Hydroxycholesterol via GSK3beta Signaling Pathway. EBioMedicine 16:238-250 |
| abstractText | While angiotensin II (ang II) has been implicated in the pathogenesis of cardiac cachexia (CC), the molecules that mediate ang II's wasting effect have not been identified. It is known TNF-alpha level is increased in patients with CC, and TNF-alpha release is triggered by ang II. We therefore hypothesized that ang II induced muscle wasting is mediated by TNF-alpha. Ang II infusion led to skeletal muscle wasting in wild type (WT) but not in TNF alpha type 1 receptor knockout (TNFR1KO) mice, suggesting that ang II induced muscle loss is mediated by TNF-alpha through its type 1 receptor. Microarray analysis identified cholesterol 25-hydroxylase (Ch25h) as the down stream target of TNF-alpha. Intraperitoneal injection of 25-hydroxycholesterol (25-OHC), the product of Ch25h, resulted in muscle loss in C57BL/6 mice, accompanied by increased expression of atrogin-1, MuRF1 and suppression of IGF-1/Akt signaling pathway. The identification of 25-OHC as an inducer of muscle wasting has implications for the development of specific treatment strategies in preventing muscle loss. |
